Literature DB >> 32798739

Highly dispersed nano-enzyme triggered intracellular catalytic reaction toward cancer specific therapy.

Xuan Mei1, Tingting Hu1, Hui Wang1, Ruizheng Liang2, Wenbo Bu3, Min Wei4.   

Abstract

Currently, reactive oxygen species (ROS)-induced apoptosis systems have drawn increasing attention in cancer therapy, owing to their specific tumor inhibition ability and great biocompatibility. Herein, we developed a highly dispersed nano-enzyme based on the assembly of natural glucose oxidase (GOD) onto CoFe-layered double hydroxides (CoFe-LDHs) monolayer nanosheets. By virtue of the high dispersion of Fe3+ within the host layer, the CoFe-LDHs nanosheets exhibit a collaborative enhanced Fenton catalytic activity with a rate constant of 3.26 × 10-4 s-1, which is 1-3 orders of magnitude higher than other iron-containing Fenton reaction agents. Subsequently, with a massive H2O2 triggered by GOD, GOD/CoFe-LDHs nanohybrid converts a cascade of glucose into hydroxyl radicals under tumor acid conditions, which is validated by a high maximum velocity (Vmax = 2.23 × 10-6 M) and low Michaelis-Menten constant (KM = 5.40 mM). Through the intracellular catalytic Fenton reaction within the tumor environment, both in vitro and in vivo results demonstrate the excellent antitumor effect of GOD/CoFe-LDHs. Therefore, a self-supplied, ultra-efficient and sequential catalytic tumor-specific therapy has been achieved based on GOD/CoFe-LDHs nano-enzyme, which holds great promise in clinical cancer therapy with minimum side effects.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer theranostic; Chemodynamic therapy; Fenton reaction; Layered double hydroxides

Mesh:

Substances:

Year:  2020        PMID: 32798739     DOI: 10.1016/j.biomaterials.2020.120257

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Defect engineering of layered double hydroxide nanosheets as inorganic photosensitizers for NIR-III photodynamic cancer therapy.

Authors:  Weicheng Shen; Tingting Hu; Xueyan Liu; Jiajia Zha; Fanqi Meng; Zhikang Wu; Zhuolin Cui; Yu Yang; Hai Li; Qinghua Zhang; Lin Gu; Ruizheng Liang; Chaoliang Tan
Journal:  Nat Commun       Date:  2022-06-13       Impact factor: 17.694

2.  Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition.

Authors:  Ruiqing He; Jie Zang; Yuge Zhao; Ying Liu; Shuangrong Ruan; Xiao Zheng; Gaowei Chong; Dailin Xu; Yan Yang; Yushan Yang; Tingting Zhang; Jingjing Gu; Haiqing Dong; Yongyong Li
Journal:  J Nanobiotechnology       Date:  2021-12-18       Impact factor: 10.435

Review 3.  Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer.

Authors:  Chengyuan Zhang; Xuemei Zhou; Hanyi Zhang; Xuanliang Han; Baijun Li; Ran Yang; Xing Zhou
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

4.  A Copper-Based Biosensor for Dual-Mode Glucose Detection.

Authors:  Kai Li; Xiaoyu Xu; Wanshan Liu; Shouzhi Yang; Lin Huang; Shuai Tang; Ziyue Zhang; Yuning Wang; Fangmin Chen; Kun Qian
Journal:  Front Chem       Date:  2022-04-04       Impact factor: 5.545

5.  Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.

Authors:  Yuan-Fei Lu; Jia-Ping Zhou; Qiao-Mei Zhou; Xiao-Yan Yang; Xiao-Jie Wang; Jie-Ni Yu; Jin-Guo Zhang; Yong-Zhong Du; Ri-Sheng Yu
Journal:  J Nanobiotechnology       Date:  2022-07-30       Impact factor: 9.429

Review 6.  Chemodynamic nanomaterials for cancer theranostics.

Authors:  Jingqi Xin; Caiting Deng; Omer Aras; Mengjiao Zhou; Chunsheng Wu; Feifei An
Journal:  J Nanobiotechnology       Date:  2021-06-28       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.